JPH0379354B2 - - Google Patents

Info

Publication number
JPH0379354B2
JPH0379354B2 JP16458683A JP16458683A JPH0379354B2 JP H0379354 B2 JPH0379354 B2 JP H0379354B2 JP 16458683 A JP16458683 A JP 16458683A JP 16458683 A JP16458683 A JP 16458683A JP H0379354 B2 JPH0379354 B2 JP H0379354B2
Authority
JP
Japan
Prior art keywords
formula
general formula
group
hydrogen atom
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP16458683A
Other languages
Japanese (ja)
Other versions
JPS6056977A (en
Inventor
Michihiro Kobayashi
Makio Kitazawa
Takenao Saito
Ryoji Yamamoto
Hiroshi Harada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kissei Pharmaceutical Co Ltd
Original Assignee
Kissei Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical Co Ltd filed Critical Kissei Pharmaceutical Co Ltd
Priority to JP16458683A priority Critical patent/JPS6056977A/en
Publication of JPS6056977A publication Critical patent/JPS6056977A/en
Publication of JPH0379354B2 publication Critical patent/JPH0379354B2/ja
Granted legal-status Critical Current

Links

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は新規なチオフエン誘導体に関するもの
である。更に詳しく述べれば、本発明は抗かいよ
う作用を有する、一般式 (式中のR1は水素原子、ハロゲン原子又はア
シル基であり、R2及びR3はそれぞれ水素原子、
低級アルキル基、アリール基又はアラルキル基で
あり、Yはアルキレンであり、nは2又は3であ
る)で表わされるチオフエン誘導体及びその製造
方法に関するものである。 本発明の一般式(1)のチオフエン誘導体は文献未
記載の新規な化合物であり、人間を含む哺乳動物
に対して顕著な抗かいよう作用を示し、胃及び十
二指腸かいようの予防及び治療用医薬品としてき
わめて有用な化合物である。 このように、本発明は医薬品として有用なチオ
フエン誘導体を提供するものであり、あわせてそ
の製造方法も提供するものである。 本発明中ハロゲン原子とは、塩素原子、臭素原
子又はヨウ素原子であり、アシル基とは炭素数2
〜7個の脂肪族及び芳香族カルボン酸から誘導さ
れる基であり、低級アルキル基とは炭素数1〜6
の直鎖状又は枝分れ状のアルキル基であり、低級
アルコキシル基とは炭素数1〜6の直鎖状又は枝
分れ状のアルコキシル基であり、アリール基とは
フエニル基、置換フエニル基及びその他芳香族炭
化水素から誘導される一価基であり、アラルキル
基とは低級アルキル基の少なくとも1個の水素原
子がアリール基によつて置換されたものであり、
アルキレンとは炭素数1〜8の脂肪族炭化水素か
ら誘導される二価基であり、酸残基とはハロゲン
原子又はベンゼンスルホニルオキシ基、D−トル
エンスルホニルオキシ基などのようなアリールス
ルホニルオキシ基など無機酸、有機酸の残基であ
る。 本発明の一般式(1)の化合物は以下のようにして
製造することができる。 例えば、一般式 (式中のR1,R2,R3,Y及びnは前記と同じ
意味をもつ)で表わされるチオフエンアミノアル
コール誘導体と、一般式 (式中のXは塩素原子又は1−イミダゾリル基
である)で表わされるカルボニル化合物とを反応
させることによつて一般式(1)の化合物を製造する
ことができる。 本製造方法で出発原料として用いられるチオフ
エンアミノアルコール誘導体(2)は一般に新規な化
合物であるが、以下のような方法によつて製造す
ることができる。 例えば、一般式 (式中のR1は前記と同じ意味をもち、Y′はア
ルキレン又は単なる結合である)で表わされるチ
オフエンカルボン酸誘導体又はその反応性官能的
誘導体と、一般式 (式中のR2,R3及びnは前記と同じ意味をも
つ)で表わされるアミノカルボン酸誘導体とを反
応させて、一般式 (式中のR1,R2,R3,Y′及びnは前記と同じ
意味をもつ)で表わされるチオフエンアミドカル
ボン酸誘導体を製し、これを適当な還元剤、例え
ば水素化アルミニウムなどで還元することによつ
て製造することができる。 又、一般式(4)のチオフエンカルボン酸誘導体又
はその反応性官能的誘導体と、一般式 (式中のR2,R3及びnは前記と同じ意味をも
つ)で表わされるアミノアルコール誘導体とを反
応させて、一般式 (式中のR1,R2,R3,Y′及びnは前記と同じ
意味をもつ)で表わされるチオフエンアミドアル
コール誘導体を製し、これを適当な還元剤、例え
ば水素化アセトキシホウ素ナトリウムなどで還元
することによつて製造することができる。 更に、一般式 (式中のR1及びY′は前記と同じ意味をもち、
R5は水素原子又は低級アルキル基である)で表
わされるチオフエン誘導体とアミノアルコール誘
導体(7)とを反応させて、一般式 (式中のR1,R2,R3,R5,Y′及びnは前記と
同じ意味をもつ)で表わされるシツフ塩基を製
し、次いでこれを適当な還元剤、例えば水素化ホ
ウ素ナトリウムなどで還元することによつて製造
することができる。 一般式(2)のチオフエンアミノアルコール誘導体
でnが3である化合物は更に、一般式 (式中のR1及びYは前記と同じ意味をもつ)
で表わされるアミノアルキルチオフエン誘導体
に、一般式 (式中のR2及びR3は前記と同じ意味をもち、
Z′はハロゲン原子又は低級アルコキシル基であ
り、R6は低級アルキル基である)で表わされる
マロン酸エステル誘導体を反応させて、一般式 (式中のR1,R2,R3,R6及びYは前記と同じ
意味をもつ)で表わされるチオフエンアミドカル
ボン酸エステル誘導体を製し、これを適当な還元
剤、例えば水素化アルミニウムなどで還元するこ
とによつても製造することができる。 これらの製造方法においてそれぞれ出発原料と
して用いられる化合物はいずれも一般に公知の化
合物であり、市販品として入手し得るか、文献記
載の方法によつて製造することができる。 このようにして製造される一般式(2)のチオフエ
ンアミノアルコール誘導体は一般に油状物であ
り、減圧蒸留又は酸付加塩の再結晶などによつて
精製することができるが、本製造方法においては
特に精製を加えることなく使用してもよい。 本製造方法のもう1つの出発原料である、一般
式(3)の化合物は公知の化合物であり、市販品とし
て入手し得るか、文献記載の方法によつて製造す
ることができる。 本製造方法を好適に実施するには、上記の方法
によつて製造したチオフエンアミノアルコール誘
導体(2)を不活性溶媒、例えばベンゼン、トルエン
などに溶解し、これに等モルないしやや過剰モル
のN,N′−カルボニルジイミダゾールを加え、
0〜80℃で3〜20時間反応させる。反応混合物を
希塩酸、炭酸水素ナトリウム水溶液及び水で順次
洗い、乾燥後溶媒を減圧下に留去し、得られる残
留物を通常の方法により精製して目的物を得る。
あるいは、チオフエンアミノアルコール誘導体(2)
を不活性溶媒、例えばベンゼン、トルエンなどに
溶解し、これに更に2〜5当量の有機第三級アミ
ン、例えばトリエチルアミンを加えた後、等モル
ないしやや過剰モルのホスゲンを加え、0〜80℃
で数時間反応させる。反応終了後上記と同様に処
理して目的物を得る。 本発明の一般式(1)で表わされる化合物は更に、
上記製造方法におけるチオフエンアミノアルコー
ル誘導体(2)に、一般式 Z−COOR4 (14) (式中のZはハロゲン原子又は低級アルコキシ
ル基であり、R4は低級アルキル基である)で表
わされる炭酸エステル誘導体を反応させて、一般
(式中のR1,R2,R3,R4,Y及びnは前記と
同じ意味をもつ)で表わされる化合物を製し、次
いでこれを塩基性触媒の存在下に加熱することに
よつて製造することができる。 更に又、本発明の一般式(1)の化合物は、一般式 (式中のR1及びYは前記と同じ意味をもち、
Aは酸残基である)で表わされるチオフエン誘導
体と、一般式 (式中のR2,R3及びnは前記と同じ意味をも
つ)で表わされる化合物とを反応させることによ
つても製造することができる。 この製造方法において出発原料として用いられ
る一般式(16)及び(17)の化合物はいずれも公知の
化合物であり、市販品として入手し得るか、文献
記載の方法によつて製造することができる。 これらの製造方法を好適に実施するには、チオ
フエンアミノアルコール誘導体(2)を不活性溶媒、
例えばジオキサン−水の混合溶液中、塩基性物
質、例えば炭酸水素ナトリウム、水酸化ナトリウ
ムなどの存在下に、やや過剰モル〜5倍モルの炭
酸エステル誘導体(14)、例えばクロル炭酸エチル
を反応させてN−アルコキシカルボニル−N−ヒ
ドロキシアルキルアミノアルキルチオフエン誘導
体(15)を製造する。次いでこの化合物を不活性溶
媒、例えばトルエン中、触媒量の塩基性物質、例
えばナトリウムメチラートなどの存在下に4〜30
時間還流する。この際反応によつて生成するアル
コールを反応系から除去すると反応が更に好適に
進行する。反応終了後不溶物をろ去して溶媒を減
圧下に留去し、残留物を通常の方法により精製し
て目的物を得る。 又、環状化合物(17)へのN−アルキル化による
製造方法を好適に実施するには、一般式(17)で表
わされる2−オキサゾリジノン誘導体又はテトラ
ヒドロ−2H−1,3−オキサジン−2−オン誘
導体を不活性溶媒、例えばN,N−ジメチルホル
ムアミド、テトラヒドロフランなどに溶解し、こ
れに塩基性物質、例えば水素化ナトリウム、炭酸
カリウムなどを加えて暫時かきまぜる。次いでこ
れに等モルないしやや過剰モルの一般式(16)で表
わされる化合物を加え、30〜150℃で3〜20時間
反応させる。反応液を減圧下に濃縮し残留物に適
量の水を加え、適当な溶媒、例えばベンゼン、ク
ロロホルム、塩化メチレンなどで抽出する。抽出
液を水洗、乾燥後減圧下に濃縮し、残留物を通常
の方法で精製して目的物を得る。 本発明の一般式(1)の化合物でR1がハロゲン原
子又はアシル基である化合物は一般式(1)の化合物
でR1が水素原子である化合物をハロゲン置換又
はアシル置換することによつても製造することが
できる。例えば、一般式(1)の化合物でR1が水素
原子である化合物を不活性溶媒、例えば酢酸中で
等モルないしやや過剰モルのハロゲン化剤、例え
ば臭素と0〜50℃で反応させることによりR1
臭素原子である化合物を製造することができ、
又、一般式(1)の化合物でR1が水素原子である化
合物を不活性溶媒、例えば酢酸中ルイス酸、例え
ば、三フツ化ホウ素エーテル錯塩の存在下に1〜
5当量のアシル化剤、例えば無水酢酸と0〜50℃
で反応させることによりR1がアセチル基である
化合物を製造することができる。 本発明の一般式(1)の化合物として、例えば3−
(2−チエニルメチル)−2−オキサゾリジノン、
3−〔2−(2−チエニル)エチル〕−2−オキサ
ゾリジノン、3−〔4−(2−チエニル)ブチル〕
−2−オキサゾリジノン、3−〔2−(5−ブロム
−2−チエニル)エチル〕−2−オキサゾリジノ
ン、3−〔2−(5−アセチル−2−チエニル)エ
チル〕−2−オキサゾリジノン、5−メチル−3
−〔2−(2−チエニル)エチル〕−2−オキサゾ
リジノン、5−エチル−3−〔2−(2−チエニ
ル)エチル〕−2−オキサゾリジノン、4−メチ
ル−3−〔2−(2−チエニル)エチル〕−2−オ
キサゾリジノン、4−エチル−3−〔2−(2−チ
エニル)エチル〕−2−オキサゾリジノン、4,
4−ジメチル−3−〔2−(2−チエニル)エチ
ル〕−2−オキサゾリジノン、4−n−プロピル
−3−〔2−(2−チエニル)エチル〕−2−オキ
サゾリジノン、4−イソプロピル−3−〔2−(2
−チエニル)エチル〕−2−オキサゾリジノン、
4−n−ブチル−3−〔2−(2−チエニル)エチ
ル〕−2−オキサゾリジノン、4−イソブチル−
3−〔2−(2−チエニル)エチル〕−2−オキサ
ゾリジノン、4−sec−ブチル−3−〔2−(2−
チエニル)エチル〕−2−オキサゾリジノン、4
−フエニル−3−〔2−(2−チエニル)エチル〕
−2−オキサゾリジノン、4−ベンジル−3−
〔2−(2−チエニル)エチル〕−2−オキサゾリ
ジノン、3−(2−チエニルメチル)テトラヒド
ロ−2H−1,3−オキサジン−2−オン、3−
(3−チエニルメチル)テトラヒドロ−2H−1,
3−オキサジン−2−オン、3−〔2−(2−チエ
ニル)エチル〕テトラヒドロ−2H−1,3−オ
キサジン−2−オン、3−〔1−(2−チエニル)
エチル〕テトラヒドロ−2H−1,3−オキサジ
ン−2−オン、3−(5−ブロム−2−チエニル
メチル)テトラヒドロ−2H−1,3−オキサジ
ン−2−オン、3−(5−アセチル−2−チエニ
ルメチル)テトラヒドロ−2H−1,3−オキサ
ジン−2−オン、5−エチル−3−〔2−(2−チ
エニル)エチル〕テトラヒドロ−2H−1,3−
オキサジン−2−オンなどをあげることができ
る。これらの化合物の中で好ましい化合物とし
て、例えば3−(2−チエニルメチル)−2−オキ
サゾリジノン、3−〔2−(2−チエニル)エチ
ル〕−2−オキサゾリジノン、5−ブロム−3−
〔2−チエニル)エチル〕−2−オキサゾリジノ
ン、4−イソプロピル−3−〔2−(2−チエニ
ル)エチル〕−2−オキサゾリジノン、3−(2−
チエニルメチル)テトラヒドロ−2H−1,3−
オキサジン−2−オン、3−〔2−(2−チエニ
ル)エチル〕テトラヒドロ−2H−1,3−オキ
サジン−2−オンなどをあげることができる。 本発明の一般式(1)の化合物は文献未記載の新規
な化合物であり、人間を含む哺乳動物のかいよう
治療剤として有用である。 本発明の一般式(1)の化合物の抗かいよう作用は
種々の実験動物を用いた実験かいようの発現抑制
効果によつて顕著に示され、特にアスピリン負荷
幽門結さつラツトにおけるかいよう発現に対し、
体重1Kg当り数mgないし百数十mgの投与量で50%
程度の抑制効果を示す。従つて本発明の一般式(1)
の化合物は人間を含む哺乳動物の胃及び十二指腸
かいようの予防及び治療用医薬品としてきわめて
有用である。 本発明の内容を以下の参考例及び実施例によつ
て更に詳細に説明する。なお、各参考例及び実施
例中における化合物の融点及び沸点はいずれも未
補正である。 参考例 1 2−チオフエンカルボン酸25.0gと塩化チオニ
ル56.7mlをベンゼン200ml中で1時間加熱還流さ
せたのち、減圧下に濃縮し、油状物の2−チオフ
エンカルボニルクロリドを得た。3−アミノ−1
−プロパノール16.1gをジオキサン100ml及び水
100mlの混液に溶かし、炭酸水素ナトリウム49.1g
を加え、室温下にかき混ぜながら、2−チオフエ
ンカルボニルクロリドを無水ジオキサン100mlに
溶かした液を滴下したのち、2時間反応させた。
反応液を減圧下に濃縮し、残留物を塩化メチレン
で抽出したのち、無水硫酸マグネシウムで乾燥し
た。減圧下に溶媒を留去し、油状物のN−(3−
ヒドロキシプロピル)−2−チオフエンカルボキ
シアミド25.5gを得た。 赤外線吸収スペクトル(液膜) 3300cm-1,1620cm-1 核磁気共鳴スペクトル(90MHz,CDCl3) δ: 1.6〜2.0(2H,m),3.4〜3.9(5H,m), 6.9〜7.6(4H,m) 水素化ホウ素ナトリウム58.1gをテトラヒドロ
フラン300mlにけんだくさせ、氷冷下にかき混ぜ
ながら、酢酸82.3gをテトラヒドロフラン450mlに
溶かした液を滴下したのち、室温で、1時間反応
させた。反応液を氷冷下にかき混ぜながら、N−
(3−ヒドロキシプロピル)−2−チオフエンカル
ボキシアミド25.4gをテトラヒドロフラン450mlに
溶かした液を滴下したのち、1.5時間加熱還流さ
せた。反応液を氷冷下にかき混ぜながら、水酸化
ナトリウム100gを水500mlに溶かした液を徐々に
加えたのち、減圧下に濃縮した。次いで、水酸化
ナトリウム100g、水300ml及びエタノール500ml
を加え、14時間加熱還流させた。反応液を減圧下
に濃縮し、残留物を塩化メチレンで抽出したの
ち、無水硫酸マグネシウムで乾燥した。減圧下に
溶媒を留去したのち、残留物を減圧蒸留し、沸点
108〜118℃/3Torrの3−(2−チエニルメチル
アミノ)−1−プロパノール13.8gを得た。 元素分析値(C8H13NOSとして) C% H% N% 計算値 56.10 7.65 8.18 実測値 56.20 7.87 8.37 赤外線吸収スペクトル(液膜) 3300cm-1 核磁気共鳴スペクトル(90MHz,CDCl3) δ: 1.72(2H,quint),2.87(2H,t), 3.10(2H,s),3.77(2H,t), 3.98(2H,s),6.8〜7.3(3H,m) 参考例 2 対応する原料を用い前記参考例1と実質的に同
様の操作を行なうことにより、下記の化合物を製
造することができた。
The present invention relates to novel thiophene derivatives. More specifically, the present invention provides a compound having the general formula (R 1 in the formula is a hydrogen atom, a halogen atom, or an acyl group, and R 2 and R 3 are each a hydrogen atom,
The present invention relates to a thiophene derivative represented by a lower alkyl group, an aryl group, or an aralkyl group, Y is alkylene, and n is 2 or 3, and a method for producing the same. The thiophene derivative of the general formula (1) of the present invention is a novel compound that has not been described in any literature, and exhibits a remarkable anti-itch effect on mammals including humans, making it extremely useful as a pharmaceutical for the prevention and treatment of gastric and duodenal ulcers. It is a useful compound. Thus, the present invention provides thiophene derivatives useful as pharmaceuticals, and also provides a method for producing the same. In the present invention, a halogen atom is a chlorine atom, a bromine atom, or an iodine atom, and an acyl group has two carbon atoms.
It is a group derived from ~7 aliphatic and aromatic carboxylic acids, and a lower alkyl group has 1 to 6 carbon atoms.
A straight-chain or branched alkyl group is a straight-chain or branched alkyl group, a lower alkoxyl group is a straight-chain or branched alkoxyl group having 1 to 6 carbon atoms, and an aryl group is a phenyl group, a substituted phenyl group. and other monovalent groups derived from aromatic hydrocarbons, and an aralkyl group is a lower alkyl group in which at least one hydrogen atom is substituted with an aryl group;
Alkylene is a divalent group derived from an aliphatic hydrocarbon having 1 to 8 carbon atoms, and acid residue is a halogen atom or an arylsulfonyloxy group such as a benzenesulfonyloxy group or a D-toluenesulfonyloxy group. It is a residue of an inorganic acid or an organic acid. The compound of general formula (1) of the present invention can be produced as follows. For example, the general formula (In the formula, R 1 , R 2 , R 3 , Y and n have the same meanings as above) and a thiophene amino alcohol derivative represented by the general formula The compound of general formula (1) can be produced by reacting with a carbonyl compound represented by (X in the formula is a chlorine atom or a 1-imidazolyl group). The thiophene amino alcohol derivative (2) used as a starting material in this production method is generally a new compound, but it can be produced by the following method. For example, the general formula (wherein R 1 has the same meaning as above and Y′ is alkylene or a simple bond) or its reactive functional derivative; (R 2 , R 3 and n in the formula have the same meanings as above) are reacted with an aminocarboxylic acid derivative represented by the general formula A thiophenamide carboxylic acid derivative represented by the formula (R 1 , R 2 , R 3 , Y' and n have the same meanings as above) is prepared, and this is treated with a suitable reducing agent such as aluminum hydride. It can be produced by reducing with Furthermore, a thiophenecarboxylic acid derivative of the general formula (4) or a reactive functional derivative thereof and a compound of the general formula (R 2 , R 3 and n in the formula have the same meanings as above) are reacted with an amino alcohol derivative represented by the general formula A thiophenamide alcohol derivative represented by the formula (R 1 , R 2 , R 3 , Y' and n have the same meanings as above) is prepared and treated with a suitable reducing agent such as sodium acetoxyborohydride. It can be produced by reducing with etc. Furthermore, the general formula (R 1 and Y′ in the formula have the same meanings as above,
A thiophene derivative represented by R 5 is a hydrogen atom or a lower alkyl group is reacted with an amino alcohol derivative (7), and the general formula (in which R 1 , R 2 , R 3 , R 5 , Y' and n have the same meanings as above) is prepared, and then treated with a suitable reducing agent such as sodium borohydride. It can be produced by reducing with etc. The thiophene amino alcohol derivative of the general formula (2), where n is 3, further has the general formula (R 1 and Y in the formula have the same meanings as above)
The aminoalkylthiophene derivative represented by the general formula (R 2 and R 3 in the formula have the same meanings as above,
Z′ is a halogen atom or a lower alkoxyl group, and R 6 is a lower alkyl group) is reacted with a malonic acid ester derivative represented by the general formula A thiophenamide carboxylic acid ester derivative represented by the formula (R 1 , R 2 , R 3 , R 6 and Y have the same meanings as above) is prepared and treated with a suitable reducing agent such as aluminum hydride. It can also be produced by reduction. The compounds used as starting materials in each of these production methods are generally known compounds and can be obtained as commercially available products or can be produced by methods described in literature. The thiophene amino alcohol derivative of general formula (2) produced in this way is generally an oily substance and can be purified by distillation under reduced pressure or recrystallization of an acid addition salt. It may be used without any particular purification. The compound of general formula (3), which is another starting material for the present production method, is a known compound and can be obtained as a commercially available product or can be produced by methods described in literature. In order to suitably carry out this production method, the thiophene amino alcohol derivative (2) produced by the above method is dissolved in an inert solvent such as benzene, toluene, etc., and an equimolar to slightly excess molar amount is dissolved therein. Add N,N'-carbonyldiimidazole,
React at 0-80°C for 3-20 hours. The reaction mixture is washed successively with dilute hydrochloric acid, an aqueous sodium bicarbonate solution, and water, and after drying, the solvent is distilled off under reduced pressure, and the resulting residue is purified by a conventional method to obtain the desired product.
Alternatively, thiophene amino alcohol derivative (2)
is dissolved in an inert solvent, such as benzene or toluene, and 2 to 5 equivalents of an organic tertiary amine, such as triethylamine, are added thereto, followed by equimolar to slightly excess molar phosgene, and the mixture is heated at 0 to 80°C.
Let it react for several hours. After the reaction is completed, the desired product is obtained by processing in the same manner as above. The compound represented by general formula (1) of the present invention further includes:
The thiophene amino alcohol derivative (2) in the above production method is represented by the general formula Z-COOR 4 (14) (in the formula, Z is a halogen atom or a lower alkoxyl group, and R 4 is a lower alkyl group). By reacting carbonate ester derivatives, the general formula (In the formula, R 1 , R 2 , R 3 , R 4 , Y and n have the same meanings as above) is prepared and then heated in the presence of a basic catalyst. It can be manufactured by Furthermore, the compound of the general formula (1) of the present invention has the general formula (R 1 and Y in the formula have the same meanings as above,
A is an acid residue) and a thiophene derivative represented by the general formula It can also be produced by reacting a compound represented by the formula (in which R 2 , R 3 and n have the same meanings as above). The compounds of general formulas (16) and (17) used as starting materials in this production method are all known compounds and can be obtained as commercially available products or can be produced by methods described in literature. In order to suitably carry out these production methods, the thiophene amino alcohol derivative (2) is mixed with an inert solvent,
For example, in a mixed solution of dioxane and water, in the presence of a basic substance such as sodium bicarbonate or sodium hydroxide, a slight molar excess to 5 times the molar amount of a carbonate derivative (14), such as ethyl chlorocarbonate, is reacted. An N-alkoxycarbonyl-N-hydroxyalkylaminoalkylthiophene derivative (15) is produced. This compound is then dissolved in an inert solvent such as toluene in the presence of a catalytic amount of a basic substance such as sodium methylate for 4 to 30 hours.
Reflux for an hour. At this time, if the alcohol produced by the reaction is removed from the reaction system, the reaction will proceed more favorably. After the reaction is complete, insoluble matter is filtered off, the solvent is distilled off under reduced pressure, and the residue is purified by a conventional method to obtain the desired product. In addition, in order to suitably carry out the production method by N-alkylation to the cyclic compound (17), a 2-oxazolidinone derivative or tetrahydro-2H-1,3-oxazin-2-one represented by the general formula (17) is used. The derivative is dissolved in an inert solvent such as N,N-dimethylformamide or tetrahydrofuran, and a basic substance such as sodium hydride or potassium carbonate is added thereto and stirred for a while. Next, equimolar to slightly excess molar amount of the compound represented by general formula (16) is added to this, and the mixture is reacted at 30 to 150°C for 3 to 20 hours. The reaction solution is concentrated under reduced pressure, an appropriate amount of water is added to the residue, and the mixture is extracted with a suitable solvent such as benzene, chloroform, methylene chloride, etc. The extract is washed with water, dried, and concentrated under reduced pressure, and the residue is purified by a conventional method to obtain the desired product. The compound of the general formula (1) of the present invention in which R 1 is a halogen atom or an acyl group can be obtained by substituting the compound of the general formula ( 1 ) with a hydrogen atom by halogen or acyl substitution. can also be manufactured. For example, by reacting a compound of general formula (1) in which R 1 is a hydrogen atom with an equimolar to slightly excess molar amount of a halogenating agent, such as bromine, in an inert solvent, such as acetic acid, at 0 to 50°C. Compounds in which R 1 is a bromine atom can be produced,
Alternatively, a compound of general formula (1) in which R 1 is a hydrogen atom is dissolved in an inert solvent such as acetic acid in the presence of a Lewis acid such as boron trifluoride ether complex salt.
5 equivalents of an acylating agent, e.g. acetic anhydride and 0-50°C.
A compound in which R 1 is an acetyl group can be produced by reacting with As the compound of general formula (1) of the present invention, for example, 3-
(2-thienylmethyl)-2-oxazolidinone,
3-[2-(2-thienyl)ethyl]-2-oxazolidinone, 3-[4-(2-thienyl)butyl]
-2-oxazolidinone, 3-[2-(5-bromo-2-thienyl)ethyl]-2-oxazolidinone, 3-[2-(5-acetyl-2-thienyl)ethyl]-2-oxazolidinone, 5-methyl -3
-[2-(2-thienyl)ethyl]-2-oxazolidinone, 5-ethyl-3-[2-(2-thienyl)ethyl]-2-oxazolidinone, 4-methyl-3-[2-(2-thienyl) ) Ethyl]-2-oxazolidinone, 4-ethyl-3-[2-(2-thienyl)ethyl]-2-oxazolidinone, 4,
4-dimethyl-3-[2-(2-thienyl)ethyl]-2-oxazolidinone, 4-n-propyl-3-[2-(2-thienyl)ethyl]-2-oxazolidinone, 4-isopropyl-3- [2-(2
-thienyl)ethyl]-2-oxazolidinone,
4-n-butyl-3-[2-(2-thienyl)ethyl]-2-oxazolidinone, 4-isobutyl-
3-[2-(2-thienyl)ethyl]-2-oxazolidinone, 4-sec-butyl-3-[2-(2-
thienyl)ethyl]-2-oxazolidinone, 4
-phenyl-3-[2-(2-thienyl)ethyl]
-2-oxazolidinone, 4-benzyl-3-
[2-(2-thienyl)ethyl]-2-oxazolidinone, 3-(2-thienylmethyl)tetrahydro-2H-1,3-oxazin-2-one, 3-
(3-thienylmethyl)tetrahydro-2H-1,
3-Oxazin-2-one, 3-[2-(2-thienyl)ethyl]tetrahydro-2H-1,3-oxazin-2-one, 3-[1-(2-thienyl)
ethyl]tetrahydro-2H-1,3-oxazin-2-one, 3-(5-bromo-2-thienylmethyl)tetrahydro-2H-1,3-oxazin-2-one, 3-(5-acetyl-2 -thienylmethyl)tetrahydro-2H-1,3-oxazin-2-one, 5-ethyl-3-[2-(2-thienyl)ethyl]tetrahydro-2H-1,3-
Examples include oxazin-2-one. Preferred among these compounds are, for example, 3-(2-thienylmethyl)-2-oxazolidinone, 3-[2-(2-thienyl)ethyl]-2-oxazolidinone, 5-bromo-3-
[2-thienyl)ethyl]-2-oxazolidinone, 4-isopropyl-3-[2-(2-thienyl)ethyl]-2-oxazolidinone, 3-(2-
thienylmethyl)tetrahydro-2H-1,3-
Examples include oxazin-2-one, 3-[2-(2-thienyl)ethyl]tetrahydro-2H-1,3-oxazin-2-one, and the like. The compound of general formula (1) of the present invention is a novel compound that has not been described in any literature, and is useful as an agent for treating ulcers in mammals including humans. The anti-inflammatory action of the compound of general formula (1) of the present invention is clearly demonstrated by the effect of suppressing the development of experimental ulcers using various experimental animals, and in particular against the expression of ulcers in aspirin-loaded pylorus-ligated rats.
50% at a dose of several mg to 100-odd mg per kg of body weight
It shows a certain degree of suppressive effect. Therefore, the general formula (1) of the present invention
The compound is extremely useful as a drug for the prevention and treatment of gastric and duodenal ulcers in mammals including humans. The content of the present invention will be explained in more detail with reference to the following reference examples and examples. Note that the melting points and boiling points of the compounds in each Reference Example and Examples are uncorrected. Reference Example 1 25.0 g of 2-thiophenecarboxylic acid and 56.7 ml of thionyl chloride were heated under reflux for 1 hour in 200 ml of benzene, and then concentrated under reduced pressure to obtain 2-thiophenecarbonyl chloride as an oil. 3-amino-1
−16.1g of propanol, 100ml of dioxane and water
Dissolved in 100ml of mixed solution, 49.1g of sodium bicarbonate
was added, and while stirring at room temperature, a solution of 2-thiophenecarbonyl chloride in 100 ml of anhydrous dioxane was added dropwise, and the mixture was allowed to react for 2 hours.
The reaction solution was concentrated under reduced pressure, the residue was extracted with methylene chloride, and then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the oily N-(3-
25.5 g of (hydroxypropyl)-2-thiophenecarboxamide was obtained. Infrared absorption spectrum (liquid film) 3300cm -1 , 1620cm -1 Nuclear magnetic resonance spectrum (90MHz, CDCl 3 ) δ: 1.6-2.0 (2H, m), 3.4-3.9 (5H, m), 6.9-7.6 (4H, m) 58.1 g of sodium borohydride was suspended in 300 ml of tetrahydrofuran, and while stirring under ice cooling, a solution of 82.3 g of acetic acid dissolved in 450 ml of tetrahydrofuran was added dropwise, and the mixture was allowed to react at room temperature for 1 hour. While stirring the reaction solution under ice-cooling, add N-
A solution of 25.4 g of (3-hydroxypropyl)-2-thiophenecarboxamide dissolved in 450 ml of tetrahydrofuran was added dropwise, and the mixture was heated under reflux for 1.5 hours. While stirring the reaction solution under ice cooling, a solution prepared by dissolving 100 g of sodium hydroxide in 500 ml of water was gradually added, and the mixture was concentrated under reduced pressure. Next, 100g of sodium hydroxide, 300ml of water and 500ml of ethanol
was added and heated under reflux for 14 hours. The reaction solution was concentrated under reduced pressure, the residue was extracted with methylene chloride, and then dried over anhydrous magnesium sulfate. After removing the solvent under reduced pressure, the residue was distilled under reduced pressure to determine the boiling point.
13.8 g of 3-(2-thienylmethylamino)-1-propanol was obtained at 108-118°C/3 Torr. Elemental analysis value (as C 8 H 13 NOS) C% H% N% Calculated value 56.10 7.65 8.18 Actual value 56.20 7.87 8.37 Infrared absorption spectrum (liquid film) 3300cm -1 Nuclear magnetic resonance spectrum (90MHz, CDCl 3 ) δ: 1.72 (2H, quint), 2.87 (2H, t), 3.10 (2H, s), 3.77 (2H, t), 3.98 (2H, s), 6.8~7.3 (3H, m) Reference example 2 Using the corresponding raw materials By performing substantially the same operation as in Reference Example 1, the following compound could be produced.

【表】【table】

【表】 参考例 3 DL−ノルバリン21.9gを1N−水酸化ナトリウ
ム水溶液190mlとジオキサン200mlの混液に溶か
し、氷冷下にかき混ぜながら、2−チエニルアセ
チルクロリド20.0gを無水ジオキサン50mlに溶か
した液と、1N−水酸化ナトリウム水溶液125mlを
滴下したのち、室温で1時間反応させた。反応液
を減圧下に濃縮し、塩酸を加えpH1としたのち、
析出した結晶をろ取し、水洗したのち、酢酸エチ
ルに加温して溶かし、無水硫酸マグネシウムで乾
燥した。減圧下に溶媒を留去したのち、残留物を
酢酸エチルベンゼンより再結晶し、融点140〜143
℃のN−(2−チエニルアセチル)ノルバリン
27.6gを得た。 元素分析値(C11H15NO3Sとして) C% H% N% 計算値 54.75 6.27 5.80 実測値 55.01 6.31 5.85 赤外線吸収スペクトル(KBr) 3350cm-1,1720cm-1,1600cm-1 核磁気共鳴スペクトル(90MHz,d6−DMSO) δ: 1.85(3H,t),1.1〜1.8(4H,m), 3.73(2H,s),4.0〜4.4(1H,m), 6.85〜7.4(3H,m),8.30(1H,d) 水素化リチウムアルミニウム23.7gをテトラヒ
ドロフラン800mlにけんだくさせ、氷冷下にかき
混ぜながら、濃硫酸30.6gを滴下したのち、4時
間反応させた。反応液を氷冷下にかき混ぜなが
ら、N−(2−チエニルアセチル)ノルバリン
27.5gをテトラヒドロフラン200mlに溶かした液を
滴下したのち、室温で17時間次いで加熱還流下に
1時間反応させた。反応液を氷冷下にかき混ぜな
がら、5%水酸化ナトリウム水溶液200mlを滴下
したのち、固体をろ去し、ろ液に水を加え、減圧
下に濃縮した。残留物を塩化メチレンで抽出し、
水洗したのち無水硫酸マグネシウムで乾燥した。
減圧下に溶媒を留去したのち、残留物を減圧蒸留
し、沸点108〜110℃/2Torrの2−〔2−(2−チ
エニル)エチルアミノ〕−1−ペンタノール13.4g
を得た。 元素分析値(C11H19NOSとして) C% H% N% 計算値 61.93 8.98 6.57 実測値 61.60 9.01 6.53 赤外線吸収スペクトル(液膜) 3300cm-1 核磁気共鳴スペクトル(90MHz,CDCl3) δ: 0.7〜1.05(3H,m),1.05〜1.5(4H, m),2.14(2H,s),2.45〜3.1(5H, m),3.26(1H,dd),3.59(1H, dd),6.7〜7.15(3H,m) 参考例 4 対応する原料を用い前記参考例3と実質的に同
様の操作を行なうことにより、下記の化合物を製
造することができた。
[Table] Reference Example 3 Dissolve 21.9 g of DL-Norvaline in a mixture of 190 ml of 1N aqueous sodium hydroxide solution and 200 ml of dioxane, and while stirring under ice-cooling, mix with a solution of 20.0 g of 2-thienylacetyl chloride dissolved in 50 ml of anhydrous dioxane. , 125 ml of 1N aqueous sodium hydroxide solution was added dropwise, and the mixture was allowed to react at room temperature for 1 hour. The reaction solution was concentrated under reduced pressure, and hydrochloric acid was added to adjust the pH to 1.
The precipitated crystals were collected by filtration, washed with water, dissolved in ethyl acetate by heating, and dried over anhydrous magnesium sulfate. After distilling off the solvent under reduced pressure, the residue was recrystallized from ethylbenzene acetate to give a melting point of 140-143.
N-(2-thienylacetyl)norvaline at °C
Obtained 27.6g. Elemental analysis value (as C 11 H 15 NO 3 S) C% H% N% Calculated value 54.75 6.27 5.80 Actual value 55.01 6.31 5.85 Infrared absorption spectrum (KBr) 3350cm -1 , 1720cm -1 , 1600cm -1 Nuclear magnetic resonance spectrum (90MHz, d6 -DMSO) δ: 1.85 (3H, t), 1.1~1.8 (4H, m), 3.73 (2H, s), 4.0~4.4 (1H, m), 6.85~7.4 (3H, m) , 8.30 (1H, d) 23.7 g of lithium aluminum hydride was suspended in 800 ml of tetrahydrofuran, 30.6 g of concentrated sulfuric acid was added dropwise while stirring under ice cooling, and the mixture was allowed to react for 4 hours. While stirring the reaction solution under ice-cooling, add N-(2-thienylacetyl)norvaline.
A solution of 27.5 g dissolved in 200 ml of tetrahydrofuran was added dropwise, and the mixture was reacted at room temperature for 17 hours and then heated under reflux for 1 hour. After 200 ml of a 5% aqueous sodium hydroxide solution was added dropwise to the reaction solution while stirring under ice-cooling, the solid was filtered off, water was added to the filtrate, and the mixture was concentrated under reduced pressure. The residue was extracted with methylene chloride,
After washing with water, it was dried over anhydrous magnesium sulfate.
After distilling off the solvent under reduced pressure, the residue was distilled under reduced pressure to obtain 13.4 g of 2-[2-(2-thienyl)ethylamino]-1-pentanol with a boiling point of 108-110°C/2 Torr.
I got it. Elemental analysis value (as C 11 H 19 NOS) C% H% N% Calculated value 61.93 8.98 6.57 Actual value 61.60 9.01 6.53 Infrared absorption spectrum (liquid film) 3300cm -1 Nuclear magnetic resonance spectrum (90MHz, CDCl 3 ) δ: 0.7 ~1.05 (3H, m), 1.05 ~ 1.5 (4H, m), 2.14 (2H, s), 2.45 ~ 3.1 (5H, m), 3.26 (1H, dd), 3.59 (1H, dd), 6.7 ~ 7.15 (3H, m) Reference Example 4 The following compound could be produced by performing substantially the same operation as in Reference Example 3 using the corresponding raw materials.

【表】【table】

【表】 参考例 5 2−(2−アミノエチル)チオフエン7.76gをジ
オキサン100ml及び水100mlの混液に溶かし、炭酸
水素ナトリウム10.3gを加え、氷冷下にかき混ぜ
ながら、2−エトキシカルボニルブチリルクロリ
ド10.9gを無水ジオキサン30mlに溶かした液を滴
下したのち、室温で17時間反応させた。反応液を
減圧下に濃縮したのち、ジエチルエーテルで抽出
し、水洗したのち、無水硫酸マグネシウムで乾燥
した。減圧下に溶媒を留去し、残留結晶として融
点46〜47℃の2−〔2−(2−チエニル)エチルカ
ルバモイル〕酪酸エチル15.2gを得た。 赤外線吸収スペクトル(KBr) 3300cm-1,1735cm-1,1640cm-1 核磁気共鳴スペクトル(90MHz,CDCl3) δ: 0.88(3H,t),1.20(3H,t),1.87 (2H,quint),3.04(2H,t),3.13 (1H,t),3.56(2H,q),4.20(2H, q),6.7〜7.2(4H,m) 水素化リチウムアルミニウム10.6gをジエチル
エーテル500mlにけんだくさせ、氷冷下にかき混
ぜながら、濃硫酸13.7gを滴下したのち、1時間
反応させた。反応液を氷冷下にかき混ぜながら、
2−〔2−(2−チエニル)エチルカルバモイル〕
酪酸エチル15.1gをジエチルエーテル50mlに溶か
した液を滴下したのち、室温で17時間反応させ
た。反応液に含水ジエチルエーテル、水及び水酸
化ナトリウム水溶液を順次滴下したのち、不溶物
をろ去し、無水硫酸マグネシウムで乾燥した。減
圧下に溶媒を留去したのち、残留物を減圧蒸留
し、沸点128〜130℃/2Torrの2−〔2−(2−チ
エニル)エチルアミノメチル〕−1−ブタノール
8.3gを得た。 元素分析値(C11H19NOSとして) C% H% N% 計算値 61.93 8.98 6.57 実測値 61.90 9.22 6.41 赤外線吸収スペクトル(液膜) 3290cm-1 核磁気共鳴スペクトル(90MHz,CDCl3) δ: 0.8〜1.9(6H,m),2.5〜4.0(10H, m),6.8〜7.3(3H,m) 参考例 6 3−チオフエンカルバルデヒド5.0gと3−アミ
ノ−1−プロパノール3.35gにベンゼン70mlを加
え、モレキユラーシーブスで還流液中の水を除去
しながら19時間加熱還流させた。冷後、反応液に
活性炭を加えろ過し、ろ液を減圧下に濃縮したの
ち、油状物として、3−(3−テニリデンアミノ)
−1−プロパノール7.5gを得た。 赤外線吸収スペクトル(液膜) 3300cm-1,1635cm-1 核磁気共鳴スペクトル(90MHz,CDCl3) δ: 1.96(2H,quint),2.98(1H,s), 3.7〜4.1(4H,m),7.1〜7.7(3H,m), 8.32(1H,s) 3−(3−テニリデンアミノ)−1−プロパノー
ル7.4gをエタノール50mlに溶かし、氷冷下にかき
混ぜながら、水素化ホウ素ナトリウム3.4gを加え
たのち、室温下に20時間反応させた。反応液に濃
塩酸を徐々に加え酸性としたのち、減圧下に濃縮
し、残留物に10%水酸化ナトリウム水溶液を加え
アルカリ性としたのち、塩化メチレンで抽出し
た。抽出液を食塩水で洗つたのち、無水硫酸マグ
ネシウムで乾燥し、減圧下に溶媒を留去したの
ち、残留物を減圧蒸留し、沸点106〜108℃/
1Torrの3−(3−チエニルメチルアミノ)−1−
プロパノール4.2gを得た。 元素分析値(C8H13NOSとして) C% H% N% 計算値 56.10 7.65 8.18 実測値 56.26 7.77 8.09 赤外線吸収スペクトル(液膜) 3300cm-1 核磁気共鳴スペクトル(90MHz,CDCl3) δ: 1.66(2H,quint),2.85(2H,t), 3.08(2H,s),3.7〜3.9(4H,m), 6.9〜7.4(3H,m) 参考例 7 2−アセチルチオフエン6.3g、3−アミノ−1
−プロパノール7.5g、p−トルエンスルホン酸
1.0g及びトルエン150mlの混合物を参考例6と同
様に反応させ処理し、油状物として、3−〔1−
(2−チエニル)エチリデンアミノ〕−1−プロパ
ノール9.1gを得た。 赤外線吸収スペクトル(液膜) 3350cm-1,1620cm-1 3−〔1−(2−チエニル)エチリデンアミノ〕
−1−プロパノール9.0gを参考例6と同様に反応
させ処理し、油状物として、3−〔1−(2−チエ
ニル)エチルアミノ〕−1−プロパノール8.3gを
得た。 赤外線吸収スペクトル(液膜) 3280cm-1 参考例 8 2−チオフエンカルバルデヒド5.0g、2−アミ
ノ−3−フエニル−1−プロパノール6.74g及び
ベンゼン100mlの混合物を参考例6と同様に反応
させ処理し、油状物として、3−フエニル−2−
(2−テニリデンアミノ)−1−プロパノール
10.9gを得た。 赤外線吸収スペクトル(液膜) 3370cm-1,1630cm-1 3−フエニル−2−(2−テニリデンアミノ)−
1−プロパノール10.8gを参考例6と同様に反応
させ、塩酸塩として、融点122.5〜124℃の、3−
フエニル−2−(2−チエニルメチルアミノ)−1
−プロパノール塩酸塩10.7gを得た。 赤外線吸収スペクトル(KBr) 3300cm-1 実施例 1 3−(2−チエニルメチルアミノ)−1−プロパ
ノール13.8gをジオキサン100ml及び水100mlの混
液に溶かし、炭酸水素ナトリウム9.5gを加え、室
温下にかき混ぜながら、クロル炭酸エチル12.3g
を無水ジオキサン20mlに溶かした液を滴下したの
ち、1時間反応させた。反応液を減圧下に濃縮し
たのち、残留物をジエチルエーテルで抽出し、水
で洗つたのち、無水硫酸マグネシウムで乾燥し
た。減圧下に溶媒を留去し、油状物のN−(3−
ヒドロキシプロピル)−N−(2−チエニルメチ
ル)カルバミン酸エチル19.3gを得た。 赤外線吸収スペクトル(液膜) 3450cm-1,1680cm-1 核磁気共鳴スペクトル(90MHz,CDCl3) δ: 1.30(3H,t),1.5〜1.9(2H,m), 2.92(1H,s),3.3〜3.7(4H,m), 4.25(2H,q),4.68(2H,s),6.8〜 7.3(3H,m) N−(3−ヒドロキシプロピル)−N−(2−チ
エニルメチル)カルバミン酸エチル19.2gとナト
リウムメチラート0.6gをトルエン300ml中で4時
間加熱還流させた。冷後、反応液を活性炭で処理
し、減圧下に濃縮したのち、残留物をベンゼン−
ヘキサンより再結晶し、融点57.5〜58.5℃の3−
(2−チエニルメチル)テトラヒドロ−2H−1,
3−オキサジン−2−オン7.4gを得た。 元素分析値(C9H11NO2Sとして) C% H% N% 計算値 54.80 5.62 7.10 実測値 54.89 5.71 7.17 赤外線吸収スペクトル(KBr) 1690cm-1 核磁気共鳴スペクトル(90MHz,d6−DMSO) δ: 1.7〜2.1(2H,m),3.28(2H,t), 4.18(2H,t),4.60(2H,s),6.9〜 7.5(3H,m) 実施例 2 1−〔2−(2−チエニル)エチルアミノ〕−2
−プロパノール9.6gとN,N′−カルボニルジイミ
ダゾール10.9gを無水ベンゼン150ml中で、室温下
に16時間かき混ぜた。析出した結晶をろ去したの
ち、ろ液を水、希塩酸、水、炭酸水素ナトリウム
水溶液及び水で順次洗い、無水硫酸マグネシウム
で乾燥した。減圧下に溶媒を留去したのち、残留
物をジエチルエーテル−ヘキサンより再結晶し、
融点35〜38℃の5−メチル−3−〔2−(2−チエ
ニル)エチル〕−2−オキサゾリジノン8.4gを得
た。 元素分析値(C10H13NO2Sとして) C% H% N% 計算値 56.85 6.20 6.63 実測値 57.02 6.16 6.75 赤外線吸収スペクトル(KBr) 1730cm-1 核磁気共鳴スペクトル(90MHz,CDCl3) δ: 1.40(3H,d),2.9〜3.3(3H,m), 3.4〜3.7(3H,m),4.4〜4.8(1H,m), 6.8〜7.3(3H,m) 実施例 3 2−オキサゾリジノン2.24gと炭酸カリウム
4.85gを無水N,N−ジメチルホルムアミド50ml
にけんだくし、室温でかき混ぜながら、2−クロ
ルメチルチオフエン3.10gを無水N,N−ジメチ
ルホルムアミド20mlに溶かした液を加えたのち、
100℃で17時間反応させた。反応液を減圧下に濃
縮したのち、残留物を塩化メチレンで抽出し、水
洗したのち、無水硫酸マグネシウムで乾燥した。
減圧下に溶媒を留去したのち、残留油状物を
1.94g得た。この油状物をシリカゲルカラムクロ
マトグラフイー(溶出溶媒、酢酸エチル−ベンゼ
ン)で精製したのち、ベンゼン−ヘキサンより再
結晶し、融点58.5〜59.5℃の3−(2−チエニル
メチル)−2−オキサゾリジノン0.44gを得た。 元素分析値(C8H9NO2Sとして) C% H% N% 計算値 52.44 4.95 7.65 実測値 52.39 4.92 7.66 赤外線吸収スペクトル(KBr) 1735cm-1 核磁気共鳴スペクトル(90MHz,d6−DMSO) δ: 3.3〜3.7(2H,m),4.2〜4.4(2H,m), 4.59(2H,s),6.9〜7.6(3H,m) 実施例 4 3−(2−チエニルメチル)テトラヒドロ−2H
−1,3−オキサジン−2−オン3.0gに無水酢酸
1.79g、酢酸3.0g及び三フツ化ホウ素エチルエー
テル錯塩31.5gを加え、室温で5時間かき混ぜた。
反応液を水に注ぎ、炭酸水素ナトリウムで中和し
たのち、クロロホルムで抽出し、水で洗つたの
ち、無水硫酸マグネシウムで乾燥した。減圧下に
溶媒を留去したのち、残留物をベンゼン−ヘキサ
ンより再結晶し、融点112〜114℃の3−(5−ア
セチル−2−チエニルメチル)テトラヒドロ−
2H−1,3−オキサジン−2−オン2.8gを得た。 元素分析値(C11H13NO3Sとして) C% H% N% 計算値 55.21 5.48 5.85 実測値 55.19 5.40 6.00 赤外線吸収スペクトル(KBr) 1670cm-1,1655cm-1 核磁気共鳴スペクトル(90MHz,CDCl3) δ: 1.9〜2.5(2H,m),2.62(3H,s), 3.49(2H,t),4.40(2H,t), 4.82(2H,s),7.18(1H,d), 7.67(1H,d) 実施例 5 3−(2−チエニルメチル)テトラヒドロ−2H
−1,3−オキサジン−2−オン3.0gを酢酸60ml
と水25mlの混液に溶かし、氷冷下にかき混ぜなが
ら、臭素2.45gを酢酸10mlに溶かした液を滴下し
たのち、室温で5分間反応させた。反応液を水に
注ぎ、クロロホルムで抽出し、水で洗つたのち、
無水硫酸マグネシウムで乾燥した。減圧下に溶媒
を留去したのち、残留物を塩化メチレン−ヘキサ
ンより再結晶し、融点95〜96℃の3−(5−ブロ
ム−2−チエニルメチル)テトラヒドロ−2H−
1,3−オキサジン−2−オン3.3gを得た。 元素分析値(C9H10NO2BrSとして) C% H% N% 計算値 39.14 3.65 5.07 実測値 39.29 3.59 4.99 赤外線吸収スペクトル(KBr) 1685cm-1 核磁気共鳴スペクトル(90MHz,CDCl3) δ: 1.9〜2.3(2H,m),3.38(2H,t), 4.29(2H,t),4.60(2H,s), 6.87(1H,d),7.00(1H,d) 実施例 6 対応する原料を用い、前記各実施例と実質的に
同様の操作を行なうことにより、以下の化合物を
製造することができた。
[Table] Reference Example 5 Dissolve 7.76 g of 2-(2-aminoethyl)thiophene in a mixture of 100 ml of dioxane and 100 ml of water, add 10.3 g of sodium hydrogen carbonate, and while stirring under ice cooling, dissolve 2-ethoxycarbonylbutyryl chloride. A solution of 10.9 g dissolved in 30 ml of anhydrous dioxane was added dropwise, and the mixture was allowed to react at room temperature for 17 hours. The reaction solution was concentrated under reduced pressure, extracted with diethyl ether, washed with water, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain 15.2 g of ethyl 2-[2-(2-thienyl)ethylcarbamoyl]butyrate having a melting point of 46 to 47°C as residual crystals. Infrared absorption spectrum (KBr) 3300cm -1 , 1735cm -1 , 1640cm -1 Nuclear magnetic resonance spectrum (90MHz, CDCl 3 ) δ: 0.88 (3H, t), 1.20 (3H, t), 1.87 (2H, quint), 3.04 (2H, t), 3.13 (1H, t), 3.56 (2H, q), 4.20 (2H, q), 6.7~7.2 (4H, m) Suspend 10.6 g of lithium aluminum hydride in 500 ml of diethyl ether. 13.7 g of concentrated sulfuric acid was added dropwise while stirring under ice cooling, and the mixture was allowed to react for 1 hour. While stirring the reaction solution under ice-cooling,
2-[2-(2-thienyl)ethylcarbamoyl]
A solution of 15.1 g of ethyl butyrate dissolved in 50 ml of diethyl ether was added dropwise, and the mixture was allowed to react at room temperature for 17 hours. Water-containing diethyl ether, water, and an aqueous sodium hydroxide solution were sequentially added dropwise to the reaction solution, and then insoluble materials were filtered off and dried over anhydrous magnesium sulfate. After distilling off the solvent under reduced pressure, the residue was distilled under reduced pressure to obtain 2-[2-(2-thienyl)ethylaminomethyl]-1-butanol with a boiling point of 128-130°C/2 Torr.
Obtained 8.3g. Elemental analysis value (as C 11 H 19 NOS) C% H% N% Calculated value 61.93 8.98 6.57 Actual value 61.90 9.22 6.41 Infrared absorption spectrum (liquid film) 3290cm -1 Nuclear magnetic resonance spectrum (90MHz, CDCl 3 ) δ: 0.8 ~1.9 (6H, m), 2.5 ~ 4.0 (10H, m), 6.8 ~ 7.3 (3H, m) Reference example 6 Add 70 ml of benzene to 5.0 g of 3-thiophenecarbaldehyde and 3.35 g of 3-amino-1-propanol. In addition, the mixture was heated under reflux for 19 hours while removing water from the reflux liquid using molecular sieves. After cooling, activated carbon was added to the reaction solution and filtered, and the filtrate was concentrated under reduced pressure to obtain 3-(3-tenylideneamino) as an oil.
7.5 g of -1-propanol was obtained. Infrared absorption spectrum (liquid film) 3300cm -1 , 1635cm -1 Nuclear magnetic resonance spectrum (90MHz, CDCl 3 ) δ: 1.96 (2H, quint), 2.98 (1H, s), 3.7-4.1 (4H, m), 7.1 ~7.7 (3H, m), 8.32 (1H, s) Dissolve 7.4 g of 3-(3-tenylideneamino)-1-propanol in 50 ml of ethanol, and add 3.4 g of sodium borohydride while stirring under ice cooling. Thereafter, the mixture was allowed to react at room temperature for 20 hours. The reaction solution was acidified by gradually adding concentrated hydrochloric acid, concentrated under reduced pressure, and the residue was made alkaline by adding 10% aqueous sodium hydroxide solution, followed by extraction with methylene chloride. After washing the extract with brine and drying over anhydrous magnesium sulfate, the solvent was distilled off under reduced pressure, and the residue was distilled under reduced pressure to obtain a boiling point of 106-108℃/
3-(3-thienylmethylamino)-1- at 1Torr
4.2 g of propanol was obtained. Elemental analysis value (as C 8 H 13 NOS) C% H% N% Calculated value 56.10 7.65 8.18 Actual value 56.26 7.77 8.09 Infrared absorption spectrum (liquid film) 3300cm -1 nuclear magnetic resonance spectrum (90MHz, CDCl 3 ) δ: 1.66 (2H, quint), 2.85 (2H, t), 3.08 (2H, s), 3.7-3.9 (4H, m), 6.9-7.4 (3H, m) Reference example 7 2-acetylthiophene 6.3g, 3- Amino-1
-Propanol 7.5g, p-toluenesulfonic acid
A mixture of 1.0 g and 150 ml of toluene was reacted and treated in the same manner as in Reference Example 6 to obtain 3-[1-
9.1 g of (2-thienyl)ethylideneamino]-1-propanol was obtained. Infrared absorption spectrum (liquid film) 3350cm -1 , 1620cm -1 3-[1-(2-thienyl)ethylideneamino]
9.0 g of -1-propanol was reacted and treated in the same manner as in Reference Example 6 to obtain 8.3 g of 3-[1-(2-thienyl)ethylamino]-1-propanol as an oil. Infrared absorption spectrum (liquid film) 3280 cm -1 Reference Example 8 A mixture of 5.0 g of 2-thiophenecarbaldehyde, 6.74 g of 2-amino-3-phenyl-1-propanol, and 100 ml of benzene was reacted and treated in the same manner as in Reference Example 6. and as an oil, 3-phenyl-2-
(2-tenylideneamino)-1-propanol
Obtained 10.9g. Infrared absorption spectrum (liquid film) 3370cm -1 , 1630cm -1 3-phenyl-2-(2-tenylideneamino)-
10.8 g of 1-propanol was reacted in the same manner as in Reference Example 6 to form 3-propanol as a hydrochloride with a melting point of 122.5-124°C.
Phenyl-2-(2-thienylmethylamino)-1
-10.7 g of propanol hydrochloride were obtained. Infrared absorption spectrum (KBr) 3300cm -1 Example 1 Dissolve 13.8g of 3-(2-thienylmethylamino)-1-propanol in a mixture of 100ml of dioxane and 100ml of water, add 9.5g of sodium hydrogen carbonate, and stir at room temperature. 12.3g of chloroethyl carbonate
A solution prepared by dissolving . After the reaction solution was concentrated under reduced pressure, the residue was extracted with diethyl ether, washed with water, and then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the oily N-(3-
19.3 g of ethyl (hydroxypropyl)-N-(2-thienylmethyl)carbamate was obtained. Infrared absorption spectrum (liquid film) 3450cm -1 , 1680cm -1 Nuclear magnetic resonance spectrum (90MHz, CDCl 3 ) δ: 1.30 (3H, t), 1.5-1.9 (2H, m), 2.92 (1H, s), 3.3 ~3.7 (4H, m), 4.25 (2H, q), 4.68 (2H, s), 6.8 ~ 7.3 (3H, m) Ethyl N-(3-hydroxypropyl)-N-(2-thienylmethyl)carbamate 19.2 g and 0.6 g of sodium methylate were heated under reflux for 4 hours in 300 ml of toluene. After cooling, the reaction solution was treated with activated carbon, concentrated under reduced pressure, and the residue was dissolved in benzene.
Recrystallized from hexane with a melting point of 57.5-58.5℃
(2-thienylmethyl)tetrahydro-2H-1,
7.4 g of 3-oxazin-2-one was obtained. Elemental analysis value (as C 9 H 11 NO 2 S) C% H% N% Calculated value 54.80 5.62 7.10 Actual value 54.89 5.71 7.17 Infrared absorption spectrum (KBr) 1690cm -1 Nuclear magnetic resonance spectrum (90MHz, d 6 -DMSO) δ: 1.7-2.1 (2H, m), 3.28 (2H, t), 4.18 (2H, t), 4.60 (2H, s), 6.9-7.5 (3H, m) Example 2 1-[2-(2 -thienyl)ethylamino]-2
-9.6 g of propanol and 10.9 g of N,N'-carbonyldiimidazole were stirred in 150 ml of anhydrous benzene at room temperature for 16 hours. After the precipitated crystals were filtered off, the filtrate was washed successively with water, dilute hydrochloric acid, water, an aqueous sodium bicarbonate solution, and water, and dried over anhydrous magnesium sulfate. After distilling off the solvent under reduced pressure, the residue was recrystallized from diethyl ether-hexane.
8.4 g of 5-methyl-3-[2-(2-thienyl)ethyl]-2-oxazolidinone with a melting point of 35-38°C was obtained. Elemental analysis value (as C 10 H 13 NO 2 S) C% H% N% Calculated value 56.85 6.20 6.63 Actual value 57.02 6.16 6.75 Infrared absorption spectrum (KBr) 1730cm -1 Nuclear magnetic resonance spectrum (90MHz, CDCl 3 ) δ: 1.40 (3H, d), 2.9-3.3 (3H, m), 3.4-3.7 (3H, m), 4.4-4.8 (1H, m), 6.8-7.3 (3H, m) Example 3 2-oxazolidinone 2.24g and potassium carbonate
4.85g to 50ml of anhydrous N,N-dimethylformamide
After stirring at room temperature, add a solution of 3.10 g of 2-chloromethylthiophene dissolved in 20 ml of anhydrous N,N-dimethylformamide.
The reaction was carried out at 100°C for 17 hours. After the reaction solution was concentrated under reduced pressure, the residue was extracted with methylene chloride, washed with water, and then dried over anhydrous magnesium sulfate.
After distilling off the solvent under reduced pressure, remove the residual oil.
Obtained 1.94g. This oily substance was purified by silica gel column chromatography (eluent: ethyl acetate-benzene) and then recrystallized from benzene-hexane. 3-(2-thienylmethyl)-2-oxazolidinone with a melting point of 58.5-59.5°C 0.44 I got g. Elemental analysis value (as C 8 H 9 NO 2 S) C% H% N% Calculated value 52.44 4.95 7.65 Actual value 52.39 4.92 7.66 Infrared absorption spectrum (KBr) 1735cm -1 Nuclear magnetic resonance spectrum (90MHz, d 6 -DMSO) δ: 3.3-3.7 (2H, m), 4.2-4.4 (2H, m), 4.59 (2H, s), 6.9-7.6 (3H, m) Example 4 3-(2-thienylmethyl)tetrahydro-2H
-1,3-oxazin-2-one 3.0g and acetic anhydride
1.79 g, 3.0 g of acetic acid, and 31.5 g of boron trifluoride ethyl ether complex salt were added, and the mixture was stirred at room temperature for 5 hours.
The reaction solution was poured into water, neutralized with sodium bicarbonate, extracted with chloroform, washed with water, and dried over anhydrous magnesium sulfate. After distilling off the solvent under reduced pressure, the residue was recrystallized from benzene-hexane to give 3-(5-acetyl-2-thienylmethyl)tetrahydro-
2.8 g of 2H-1,3-oxazin-2-one was obtained. Elemental analysis value (as C 11 H 13 NO 3 S) C% H% N% Calculated value 55.21 5.48 5.85 Actual value 55.19 5.40 6.00 Infrared absorption spectrum (KBr) 1670cm -1 , 1655cm -1 Nuclear magnetic resonance spectrum (90MHz, CDCl 3 ) δ: 1.9~2.5 (2H, m), 2.62 (3H, s), 3.49 (2H, t), 4.40 (2H, t), 4.82 (2H, s), 7.18 (1H, d), 7.67 ( 1H, d) Example 5 3-(2-thienylmethyl)tetrahydro-2H
-1,3-oxazin-2-one 3.0g in acetic acid 60ml
A solution of 2.45 g of bromine dissolved in 10 ml of acetic acid was added dropwise while stirring under ice-cooling, and the mixture was allowed to react at room temperature for 5 minutes. The reaction solution was poured into water, extracted with chloroform, washed with water, and then
It was dried with anhydrous magnesium sulfate. After distilling off the solvent under reduced pressure, the residue was recrystallized from methylene chloride-hexane to give 3-(5-bromo-2-thienylmethyl)tetrahydro-2H- with a melting point of 95-96°C.
3.3 g of 1,3-oxazin-2-one was obtained. Elemental analysis value (as C 9 H 10 NO 2 BrS) C% H% N% Calculated value 39.14 3.65 5.07 Actual value 39.29 3.59 4.99 Infrared absorption spectrum (KBr) 1685cm -1 Nuclear magnetic resonance spectrum (90MHz, CDCl 3 ) δ: 1.9-2.3 (2H, m), 3.38 (2H, t), 4.29 (2H, t), 4.60 (2H, s), 6.87 (1H, d), 7.00 (1H, d) Example 6 Corresponding raw materials The following compounds were able to be produced by using substantially the same procedure as in each of the above Examples.

【表】【table】

【表】【table】

【表】【table】

Claims (1)

【特許請求の範囲】 1 一般式 (式中のR1は水素原子、ハロゲン原子又はア
シル基であり、R2及びR3はそれぞれ水素原子、
低級アルキル基、アリール基又はアラルキル基で
あり、Yはアルキレンであり、nは2又は3であ
る)で表わされるチオフエン誘導体。 2 nが2である特許請求の範囲第1項記載のチ
オフエン誘導体。 3 nが3である特許請求の範囲第1項記載のチ
オフエン誘導体。 4 一般式 (式中のR1は水素原子、ハロゲン原子又はア
シル基であり、R2及びR3はそれぞれ水素原子、
低級アルキル基、アリール基又はアラルキル基で
あり、Yはアルキレンであり、nは2又は3であ
る)で表わされるチオフエンアミノアルコール誘
導体と、一般式 (式中のXは塩素原子又は1−イミダゾリル基
である)で表わされるカルボニル化合物とを反応
させることを特徴とする、一般式 (式中のR1,R2,R3,Y及びnは前記と同じ
意味をもつ)で表わされるチオフエン誘導体の製
造方法。 5 一般式 (式中のR1は水素原子、ハロゲン原子又はア
シル基であり、R2及びR3はそれぞれ水素原子、
低級アルキル基、アリール基又はアラルキル基で
あり、Yはアルキレンであり、nは2又は3であ
る)で表わされるチオフエンアミノアルコール誘
導体に、一般式 Z−COOR4 (式中のZはハロゲン原子又は低級アルコキシ
ル基であり、R4は低級アルキル基である)で表
わされる化合物を反応させて、一般式 (式中のR1,R2,R3,R4,Y及びnは前記と
同じ意味をもつ)で表わされる化合物を製し、次
いでこれを加熱閉環させることを特徴とする、一
般式 (式中のR1,R2,R3,Y及びnは前記と同じ
意味をもつ)で表わされるチオフエン誘導体の製
造方法。 6 一般式 (式中のR1は水素原子、ハロゲン原子又はア
シル基であり、Yはアルキレンであり、Aは酸残
基である)で表わされるチオフエン誘導体と、一
般式 (式中のR2及びR3はそれぞれ水素原子、低級
アルキル基、アリール基又はアラルキル基であ
り、nは2又は3である)で表わされる環状化合
物とを反応させることを特徴とする、一般式 (式中のR1,R2,R3,Y及びnは前記と同じ
意味をもつ)で表わされるチオフエン誘導体の製
造方法。
[Claims] 1. General formula (R 1 in the formula is a hydrogen atom, a halogen atom, or an acyl group, and R 2 and R 3 are each a hydrogen atom,
A thiophene derivative represented by a lower alkyl group, an aryl group, or an aralkyl group, Y is alkylene, and n is 2 or 3. 2. The thiophene derivative according to claim 1, wherein n is 2. 3. The thiophene derivative according to claim 1, wherein n is 3. 4 General formula (R 1 in the formula is a hydrogen atom, a halogen atom, or an acyl group, and R 2 and R 3 are each a hydrogen atom,
a lower alkyl group, an aryl group, or an aralkyl group, Y is alkylene, and n is 2 or 3), and a thiophene amino alcohol derivative represented by the general formula A general formula characterized by reacting with a carbonyl compound represented by (X in the formula is a chlorine atom or a 1-imidazolyl group) A method for producing a thiophene derivative represented by the formula (R 1 , R 2 , R 3 , Y and n have the same meanings as above). 5 General formula (R 1 in the formula is a hydrogen atom, a halogen atom, or an acyl group, and R 2 and R 3 are each a hydrogen atom,
is a lower alkyl group, an aryl group, or an aralkyl group, Y is alkylene, and n is 2 or 3 ). or a lower alkoxyl group, and R 4 is a lower alkyl group) to form a compound represented by the general formula (In the formula, R 1 , R 2 , R 3 , R 4 , Y and n have the same meanings as above) is prepared and then ring-closed by heating. A method for producing a thiophene derivative represented by the formula (R 1 , R 2 , R 3 , Y and n have the same meanings as above). 6 General formula (In the formula, R 1 is a hydrogen atom, a halogen atom, or an acyl group, Y is an alkylene, and A is an acid residue) and a thiophene derivative represented by the general formula (In the formula, R 2 and R 3 are each a hydrogen atom, a lower alkyl group, an aryl group, or an aralkyl group, and n is 2 or 3.) formula A method for producing a thiophene derivative represented by the formula (R 1 , R 2 , R 3 , Y and n have the same meanings as above).
JP16458683A 1983-09-07 1983-09-07 Thiophene derivative and production thereof Granted JPS6056977A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP16458683A JPS6056977A (en) 1983-09-07 1983-09-07 Thiophene derivative and production thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16458683A JPS6056977A (en) 1983-09-07 1983-09-07 Thiophene derivative and production thereof

Publications (2)

Publication Number Publication Date
JPS6056977A JPS6056977A (en) 1985-04-02
JPH0379354B2 true JPH0379354B2 (en) 1991-12-18

Family

ID=15795985

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16458683A Granted JPS6056977A (en) 1983-09-07 1983-09-07 Thiophene derivative and production thereof

Country Status (1)

Country Link
JP (1) JPS6056977A (en)

Also Published As

Publication number Publication date
JPS6056977A (en) 1985-04-02

Similar Documents

Publication Publication Date Title
JP6049791B2 (en) Activator of peroxisome proliferator activated receptor δ
RU2501794C2 (en) Activating agent for receptor activated by peroxisome growth-stimulating agents
KR20130004257A (en) Production method
FR2654725A1 (en) NOVEL DERIVATIVES OF ISOINDOLONE, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
CS199694B2 (en) Process for preparing 5-/phenyl substituted/-oxazolidinone and sulphur derivatives thereof
US6160123A (en) One pot synthesis of 2-oxazolidinone derivatives
JP2006524686A (en) Use of 2,4-dihydro- [1,2,4] triazole-3-thione derivatives as inhibitors of myeloperoxidase enzyme (MPO)
EP0385043A1 (en) New derivatives of 4-substituted piperazines
FR2675800A1 (en) HETEROCYCLIC ANTISEROTONINE DERIVATIVES AND PREPARATION AND MEDICAMENTS CONTAINING SAME.
CS237346B2 (en) Processing of racemic or opticaly active 5-substituted oxazolidine-2,4-dione
WO2007068815A2 (en) Heterocyclic derivatives, preparation and therapeutic use thereof
CN1097744A (en) Contain the heterocyclic urea derivative
US4450165A (en) Dihydropyridine compounds
KR850000668B1 (en) Process for preparing heterocyclic derivatives
SU1042612A3 (en) Process for preparing derivatives of indole or their salts
US5574030A (en) N-aminoalkyl-substituted nitrogen-containing five membered heterocyclic compounds
JPH0256471A (en) Novel (hetero)aryl substituted diazole derivative, its production and adaptation thereof to treatment
JPH0379354B2 (en)
NO127054B (en)
US4090020A (en) Thienothiazine derivatives
CN114105970A (en) Preparation method of rivaroxaban
EP0579169B1 (en) Alkylenediamine derivatives
JP2003531146A (en) Method for producing thiazolidinedione derivative and intermediate
US4175085A (en) Thienothiazine derivatives
JPS6147477A (en) Novel 1,4-dihydropyridine-3,5-dicarboxylic acid ester derivative